This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Another Nail in the Coffin

Richard D. Baughman, MD

Arch Dermatol. 1993;129(10):1329-1330.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

IN THEIR prospective, double-blind, placebocontrolled study in this issue of the ARCHIVES, Reitamo et al¹ have demonstrated that palmoplantar pustulosis (PPP) is responsive to low-dose (1.25-to 2.5-mg/kg per day) oral cyclosporine. Increases in serum creatinine concentrations occurred but did not exceed normal limits, and blood pressure level increases were not noted at these doses. Simply having another therapeutic alternative for this vexing and often incapacitating problem would be welcome in itself. In addition, however, remissions exceeded expectations. In follow-up of 4 to 14 months after cessation of therapy, 27 of 38 patients remained "in remission" and 10 of the 27 patients in remission had no signs of PPP at all, despite the fact that there was no change in the behavioral risk factor most commonly associated with PPP, namely, cigarette smoking.

Buried in Table 1¹ is the fact that all 40 of the original patients were, at the . . . [Full Text PDF of this Article]

Author Affiliations
Section of Dermatology Hitchcock Clinic Lebanon, NH 03756

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?